JPMorgan Eyes Upside in European Staples, Upgrades Reckitt and Puts Heineken, Unilever on Watch

JPMorgan has placed consumer products giants Heineken and Unilever on its 'positive catalyst watch' list, signaling potential for near-term stock gains, while upgrading household goods maker Reckitt to Overweight. The moves came as part of a broader review of the European consumer staples sector heading into the 2027 fiscal year, according to a note from the investment bank.

Key Analyst Actions

In a research note led by analyst Celine Pannuti, JPMorgan outlined several key ratings changes and outlooks for major European consumer goods companies. The bank's most notable calls include:

• Heineken (HEIN): Placed on positive catalyst watch ahead of what JPMorgan expects will be a third-quarter earnings beat. The bank forecasts 4.0% like-for-like growth, ahead of the market consensus of 3.4%.
• Unilever (ULVR): Also placed on positive catalyst watch, following a strong second-quarter topline result. Analysts see potential upside to third-quarter volumes and 2026 margins, with a Capital Markets Day scheduled for November 4.
• Reckitt (RKT): Upgraded to Overweight, with the bank citing a "stronger Core run rate and potential for settlement getting closer on NEC litigation."

Sector Performance and Valuation

JPMorgan noted that the European staples sector has underperformed year-to-date, even as many companies reported topline and earnings beats. The market has instead favored sectors with stronger earnings-per-share (EPS) growth and upward revisions.

Ad

Currently, the sector trades at 18 times forward earnings, representing a 23% premium to the broader market. According to the note, this is significantly below the long-term average valuation premium of 43%. Analysts expect "cautiously optimistic messages" from companies in the second half of the year, driven by momentum in emerging markets and early signs of price increases.

Broader Outlook and Risks

Beyond its top picks, JPMorgan expressed a preference for Danone and Givaudan within the food and ingredients space. However, the bank remains cautious on Haleon and Essity in home care and hygiene, and is on the sidelines for L’Oréal due to its premium valuation and decelerating growth.

Looking ahead, the analysts flagged potential downside risk to 2027 consensus earnings estimates, primarily due to margin pressure from rising input costs. Key themes shaping the sector for the remainder of the year include accelerating emerging-market growth, uncertain U.S. consumer trends, and the impact of structural changes like AI adoption and GLP-1 drugs on consumer behavior.